Related changes

Jump to navigation Jump to search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 11:11, 20 May 2024
   
Page name:
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

19 May 2024

 m   01:07  Diffuse large B-cell lymphoma‎‎ 2 changes history +66 [Jwarner‎ (2×)]
 m   
01:07 (cur | prev) +21 Jwarner talk contribs →‎R-ESHAP {{#subobject:7794d|Regimen=1}}
 m   
01:05 (cur | prev) +45 Jwarner talk contribs →‎Regimen {{#subobject:b6038c|Variant=1}}
 m   00:38  Mantle cell lymphoma diffhist +17 Jwarner talk contribs →‎Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}}

17 May 2024

 m   18:28  Follicular lymphoma diffhist +636 Jwarner talk contribs
 m   18:25  Diffuse large B-cell lymphoma diffhist +468 Jwarner talk contribs →‎References

16 May 2024

 m   00:39  Follicular lymphoma‎‎ 11 changes history -23,293 [Jwarner‎ (11×)]
 m   
00:39 (cur | prev) -6,881 Jwarner talk contribs →‎Consolidation after subsequent lines of therapy
 m   
00:37 (cur | prev) +105 Jwarner talk contribs →‎Relapsed or refractory, randomized data
 m   
00:36 (cur | prev) -1,395 Jwarner talk contribs →‎Maintenance after first-line therapy
 m   
00:34 (cur | prev) -12,670 Jwarner talk contribs →‎Consolidation after first-line therapy
 m   
00:31 (cur | prev) +35 Jwarner talk contribs →‎Advanced disease, first-line therapy, non-randomized or retrospective data
 m   
00:31 (cur | prev) +4,108 Jwarner talk contribs →‎Rituximab and hyaluronidase monotherapy {{#subobject:hfn369|Regimen=1}}
 m   
00:31 (cur | prev) -3,990 Jwarner talk contribs →‎Advanced disease, first-line therapy, randomized data
 m   
00:29 (cur | prev) +105 Jwarner talk contribs →‎Early disease, definitive therapy
 m   
00:26 (cur | prev) -2,859 Jwarner talk contribs →‎Early disease, adjuvant therapy
 m   
00:25 (cur | prev) +29 Jwarner talk contribs
 m   
00:24 (cur | prev) +120 Jwarner talk contribs
 m   00:00  Mantle cell lymphoma diffhist -33 Jwarner talk contribs →‎First-line therapy, non-randomized or retrospective data

15 May 2024

 m   11:37  Cutaneous T-cell lymphoma diffhist -7 Warner-admin talk contribs Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''"
 m   11:36  Multiple myeloma diffhist -7 Warner-admin talk contribs Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''"
 m   11:36  Waldenström macroglobulinemia diffhist -7 Warner-admin talk contribs Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''"
 m   11:35  Follicular lymphoma diffhist -7 Warner-admin talk contribs Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''"
 m   11:33  Hodgkin lymphoma, nodular lymphocyte-predominant diffhist -7 Warner-admin talk contribs Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''"